InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+130.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Baker G Leonard Jr, 董事. Officer active across 2 companies, notably Corcept Therapeutics INC. Cumulatively, 7 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €3.1m. History available since 18 May 2021. The latest transaction was disclosed on 17 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Baker G Leonard Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
75,782 股@ US$33.002267.5% 占其流量Common StockSEC:0001201715-26-000007:0
标准退出：2026年6月15日 (T+90)
30,000 股@ US$5.864.4% 占其流量Common StockSEC:0001201715-26-000005:0
00Common StockSEC:0001201715-26-000003:0
00Common StockSEC:0001225208-25-000061:0
00Common StockSEC:0001225208-23-007580:0
50,000 股@ US$21.5326.3% 占其流量Common StockSEC:0001225208-21-009444:0
标准退出：2021年9月9日 (T+90)
30,000 股@ US$6.554.8% 占其流量Common StockSEC:0001225208-21-008372:0
7 条申报中的 7 条
About Baker G Leonard Jr
Leonard G. Baker Jr. is a Director at CORCEPT THERAPEUTICS INC. As a board member, he contributes to the governance of the company and strategic decision-making. Leonard brings valuable expertise in the biotechnology field, helping CORCEPT navigate a complex environment and focus on innovation. His commitment to excellence is an asset to the company.
